Given this carrier frequency, the expected incidence of perinatal OI due to homozygosity for this mutation would be 1 in 160,000 births; one infant with LEPRE1-related OI caused by this mutation once every 3–4 years in T&T. This evidence concerns the gene P3H1 and osteogenesis imperfecta.